Curated News
By: NewsRamp Editorial Staff
May 15, 2026
Nutriband to Showcase New Wellness Products at ECRM Conference
TLDR
- Nutriband (NTRB) expands retail partnerships with new wellness products, gaining an edge in the consumer health market.
- Active Intelligence showcases AI Tape, Performance Tape, Energy Patches, and Sleep patches at ECRM to secure distribution deals.
- Nutriband's transdermal patches aim to prevent drug abuse and improve wellness, making tomorrow safer and healthier.
- Nutriband introduces AI Energy and Sleep patches, merging transdermal tech with everyday recovery and performance needs.
Impact - Why it Matters
This news matters because it signals Nutriband's strategic expansion beyond its core pharmaceutical focus into the consumer wellness market, potentially opening new revenue streams. For investors, it demonstrates the company's efforts to diversify and grow its product portfolio, which could enhance shareholder value. For consumers, the introduction of AI Performance Tape, AI Energy Patches, and AI Sleep patches offers innovative solutions for recovery, energy, and sleep—areas of high demand. The company's established expertise in transdermal technology could give it a competitive edge in delivering effective wellness products.
Summary
Nutriband (NASDAQ: NTRB) is making strategic moves to expand its consumer wellness product line. The company announced that its wholly owned subsidiary, Active Intelligence, will participate in the June 2026 ECRM conference. At this event, Nutriband plans to showcase its growing portfolio of wellness, recovery, and performance-focused products to buyers from major retail, pharmacy, and healthcare organizations. The company will feature its existing AI Tape line and introduce new products including AI Performance Tape, AI Energy Patches, and AI Sleep patches. This initiative is aimed at expanding retail partnerships and distribution opportunities for Nutriband's consumer product segment.
Beyond consumer products, Nutriband is primarily engaged in developing a portfolio of transdermal pharmaceutical products. Its lead product is an abuse-deterrent fentanyl patch that incorporates the company's AVERSA™ abuse-deterrent technology. This technology can be integrated into any transdermal patch to prevent abuse, misuse, diversion, and accidental exposure of drugs with abuse potential. The dual focus on both consumer wellness and pharmaceutical innovation positions Nutriband uniquely in the market.
For investors, the latest news and updates regarding NTRB are available in the company's newsroom. The press release was distributed by BioMedWire, a specialized communications platform focused on the Biotechnology, Biomedical Sciences, and Life Sciences sectors. BioMedWire is part of the Dynamic Brand Portfolio within IBN, which provides a range of services including press release distribution, editorial syndication, and social media outreach. The full press release can be accessed at the provided link.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, Nutriband to Showcase New Wellness Products at ECRM Conference
